Mr. Terrillion joined Cara in 2016 as the company’s General Counsel. Scott oversees Cara’s legal and compliance functions and serves as company Secretary.
Mr. Terrillion brings over 20 years of diverse pharmaceutical industry experience from varying legal and business roles in the public, private and not-for-profit sectors. Mr. Terrillion spent 15 years at Boehringer Ingelheim Pharmaceuticals, Inc., where he served as Vice President, Associate General Counsel. At Boehringer, Mr. Terrillion built and led the legal team supporting the global company’s US human pharmaceutical business during a period of rapid, industry-leading growth. Mr. Terrillion also spent two years at Mesoblast, Inc., a publicly traded emerging biotech, as the company’s Vice President, Associate General Counsel and Head of Compliance. Mr. Terrillion began his legal career at Nixon, Hargrave, Devans & Doyle (now Nixon Peabody), a large general practice law firm, where he was an associate in the Health Care and Technology/Intellectual Property Practice groups. A licensed pharmacist, Mr. Terrillion began his professional career as a community pharmacist and later served as Director of Pharmacy for Preferred Care, Inc., a HMO insurance provider.
Mr. Terrillion received his B.S. in Pharmacy from the Albany College of Pharmacy and Health Sciences, where he serves on the Board of Trustees, and a Juris Doctor, magna cum laude, from Albany Law School. He is a member of the New York bar.
What is Scott Terrillion's net worth?
The estimated net worth of Scott Terrillion is at least $28,759.37 as of February 8th, 2024. Mr. Terrillion owns 94,293 shares of Cara Therapeutics stock worth more than $28,759 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Terrillion may own. Additionally, Mr. Terrillion receives a salary of $689,630.00 as Insider at Cara Therapeutics. Learn More about Scott Terrillion's net worth.
How old is Scott Terrillion?
What is Scott Terrillion's salary?
As the Insider of Cara Therapeutics, Inc., Mr. Terrillion earns $689,630.00 per year. The highest earning executive at Cara Therapeutics is Mr. Christopher A. Posner, President, CEO & Director, who commands a salary of $1,150,000.00 per year. Learn More on Scott Terrillion's salary.
How do I contact Scott Terrillion?
Has Scott Terrillion been buying or selling shares of Cara Therapeutics?
Scott Terrillion has not been actively trading shares of Cara Therapeutics over the course of the past ninety days. Most recently, Scott Terrillion sold 7,770 shares of the business's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $0.53, for a transaction totalling $4,118.10. Following the completion of the sale, the insider now directly owns 94,293 shares of the company's stock, valued at $49,975.29. Learn More on Scott Terrillion's trading history.
Who are Cara Therapeutics' active insiders?
Are insiders buying or selling shares of Cara Therapeutics?
In the last year, insiders at the biopharmaceutical company sold shares 6 times. They sold a total of 60,503 shares worth more than $33,858.03. The most recent insider tranaction occured on May, 2nd when CEO Christopher Posner sold 3,936 shares worth more than $2,952.00. Insiders at Cara Therapeutics own 3.1% of the company.
Learn More about insider trades at Cara Therapeutics. Information on this page was last updated on 5/2/2024.
